Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non-cash Items (2020 - 2025)

Terns Pharmaceuticals filings provide 6 years of Non-cash Items readings, the most recent being $2.0 million for Q4 2025.

  • Quarterly Non-cash Items fell 91.27% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, down 91.27% year-over-year, with the annual reading at $2.0 million for FY2025, 60.36% down from the prior year.
  • Non-cash Items hit $2.0 million in Q4 2025 for Terns Pharmaceuticals, down from $6.0 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $28.4 million in Q1 2022 and bottomed at $300000.0 in Q2 2022.
  • Average Non-cash Items over 5 years is $6.3 million, with a median of $4.4 million recorded in 2024.
  • The largest annual shift saw Non-cash Items crashed 97.74% in 2021 before it soared 2287.17% in 2022.
  • Terns Pharmaceuticals' Non-cash Items stood at $491000.0 in 2021, then soared by 2287.17% to $11.7 million in 2022, then crashed by 81.02% to $2.2 million in 2023, then soared by 951.69% to $23.4 million in 2024, then tumbled by 91.27% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for TERN's Non-cash Items are $2.0 million (Q4 2025), $6.0 million (Q3 2025), and $5.7 million (Q2 2025).